Apogee Entertainment has brought Turbo Overkill’s explosive action and chainsaw-fueled mayhem to Xbox Series X/S. This brutal cyberpunk first-person shooter has been on PC for over a year now ...

APG990’s Phase 1 trial showed a 60-day half-life, supporting three- and six-month dosing. Apogee plans a 2025 Phase 1b trial comparing APG279 to Dupixent in atopic dermatitis. Our government tra ...

In a report released yesterday, Charlie CY Yang from Bank of America Securities maintained a Buy rating on Apogee Therapeutics (APGE – Research Report), with a price target of $80.00.

Apogee Therapeutics (NASDAQ:APGE – Get Free Report) ‘s stock had its “buy” rating reissued by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga ...